^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
iC9.GD2.CAR.IL-15 T-cells
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
UNC Lineberger Comprehensive Cancer Center
Drug class:
IL-15R stimulant, GD2-targeted CAR-T immunotherapy
Related drugs:
